Betül YAZMACI, Muhammed DEMİR, Mehmet Sinan DOĞAN

Osteogenesis Imperfecta

Osteogenesis Imperfecta (OI), also known as glass bone disease; It is an autosomal dominant inherited disease with a prevalence of approximately 1/15,000-1/20,000, with clinical findings such as increased bone fragility, blue sclera, dental disorders, dentinogenesis imperfecta, hearing loss, ligamentous laxity, long bone fractures and deformities. In OI, which is the most common cause of genetically-induced osteoporosis, long bone fractures and vertebral compression fractures are seen after a simple trauma. In OI patients, dental anomalies are seen clinically as dentinogenesis imperfecta (DI), malocclusion, mandibular prognathism, and decrease in vertical dimension. In this article, it is aimed to evaluate an important bone disease such as osteogenesis imperfecta by emphasizing its clinical and oral findings.

Keywords:

Osteogenesis imperfecta blue sclera, brittle bone disease, dentinogenesis imperfecta.,

PDF

___

1. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet (London, England). 2004;363(9418):1377-85.
2. Forlino A, Marini JC. Osteogenesis imperfecta. Lancet (London, England). 2016;387(10028):1657-71.
3. Apolinário AC, Sindeaux R, de Souza Figueiredo PT, Guimarães AT, Acevedo AC, Castro LC, et al. Dental panoramic indices and fractal dimension measurements in osteogenesis imperfecta children under pamidronate treatment. Dento maxillo facial radiology. 2016;45(4):20150400.
4. Huber MA. Osteogenesis imperfecta. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2007;103(3):314-20.
5. Valadares ER, Carneiro TB, Santos PM, Oliveira AC, Zabel B. What is new in genetics and osteogenesis imperfecta classification? Jornal de pediatria. 2014;90(6):536-41.
6. Gurbuz T, Selcuk M, Ozbek E. Osteogenesis Imperfecta: A Case Report. J Dent Fac Ataturk Univ. 2007;17(3):48-51.
7. Palomo T, Vilaça T, Lazaretti-Castro M. Osteogenesis imperfecta: diagnosis and treatment. Current opinion in endocrinology, diabetes, and obesity. 2017;24(6):381-8.
8. Sogukpınar A, Hatipoglu O. Dental Treatment of Patients with Osteogenesis Imperfecta: A Case Report. J Dent Fac Ataturk Univ. 2021;31(2):275-8.
9. Malmgren B, Norgren S. Dental aberrations in children and adolescents with osteogenesis imperfecta. Acta odontologica Scandinavica. 2002;60(2):65-71.
10. Abukabbos H, Al-Sineedi F. Clinical manifestations and dental management of dentinogenesis imperfecta associated with osteogenesis imperfecta: Case report. The Saudi dental journal. 2013;25(4):159-65.
11. Oztas B, Kursun S, Sehrazat O, Gultekin SE. Osteogenesis Imperfecta: A Case Report. J European Annals of Dental Sciences. 2008;35:95-8.
12. Aizenbud D, Peled M, Figueroa AA. A combined orthodontic and surgical approach in osteogenesis imperfecta and severe Class III malocclusion: case report. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2008;66(5):1045- 53.
13. Eren E, Sincar S, Cakır EDP, Saglam H, Tarım O. Efficacy of bisphosphonates in patients with osteogenesis imperfecta The Journal of Current Pediatrics. 2011;10(1):122-6.
14. de La Dure-Molla M, Philippe Fournier B, Berdal A. Isolated dentinogenesis imperfecta and dentin dysplasia: revision of the classification. European journal of human genetics : EJHG. 2015;23(4):445-51.
15. Kehribar MA, Baltacıoglu E, Yazıcı A. Dental Approach In A Patient with Type III Osteogenesis Imperfecta: A case report. Selcuk Dental Journal. 2021;8(3):845-9.
16. O'Connell AC, Marini JC. Evaluation of oral problems in an osteogenesis imperfecta population. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 1999;87(2):189-96.
17. Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. The Cochrane database of systematic reviews. 2016;10(10):Cd005088.